Reading the tape
NASDAQ: IRON
Disc Medicine, Inc.
Healthcare · Biotechnology
Market Cap
$2.55B
52w High
$99.50
52w Low
$40.00
P/E
-11.13
Volume
399.18K
Outstanding Shares
38.16M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 34.68%FCF (TTM): -92.02%
What changed
The stock rose 34.68% over the last year. Free cash flow declined 92.02% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly weakening underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
A decisive shift in revenue or cash flow over the next period would be the clearest signal to resolve the ambiguity.
Company profile
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases.
CEOJohn D. Quisel
SectorHealthcare
IndustryBiotechnology
Employees94
IPO dateAug 12, 2020
Valuation
Forward P/E—
EV/EBITDA-13.05
Enterprise value$2.71B
Stock splits
Dec 30, 2022↓ Reverse
Every 10 shares became 1
Profitability & growth
Revenue growth—
Gross margin0%
Operating margin0%
ROE-28.68%▼16.34%vs FY2024
Analyst consensus
RatingBuy
Target price$104.14▲55.64%
11
Buy
0
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 7, 2026
Q2 FY26 · EPS est -$1.62 · Revenue est $437.5K
View